Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Oligodendroglioma cell lines containing t(1;19)(q10;p10).

Kelly JJ, Blough MD, Stechishin OD, Chan JA, Beauchamp D, Perizzolo M, Demetrick DJ, Steele L, Auer RN, Hader WJ, Westgate M, Parney IF, Jenkins R, Cairncross JG, Weiss S.

Neuro Oncol. 2010 Jul;12(7):745-55. doi: 10.1093/neuonc/noq031. Epub 2010 Apr 13.

2.

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.

Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, Flynn H, Passe S, Felten S, Brown PD, Shaw EG, Buckner JC.

Cancer Res. 2006 Oct 15;66(20):9852-61.

3.

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

Griffin CA, Burger P, Morsberger L, Yonescu R, Swierczynski S, Weingart JD, Murphy KM.

J Neuropathol Exp Neurol. 2006 Oct;65(10):988-94.

PMID:
17021403
4.

A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.

Gadji M, Crous-Tsanaclis AM, Mathieu D, Mai S, Fortin D, Drouin R.

Neuropathology. 2014 Apr;34(2):170-8. doi: 10.1111/neup.12060. Epub 2013 Sep 30.

PMID:
24118308
5.

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.

J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9.

PMID:
9776413
7.

MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status.

Sherman JH, Prevedello DM, Shah L, Raghavan P, Pouratian N, Starke RM, Lopes MB, Shaffrey ME, Schiff D.

Acta Neurochir (Wien). 2010 Nov;152(11):1827-34. doi: 10.1007/s00701-010-0743-1. Epub 2010 Aug 15.

PMID:
20711790
8.

NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.

Benetkiewicz M, Idbaih A, Cousin PY, Boisselier B, Marie Y, Crinière E, Hoang-Xuan K, Delattre JY, Sanson M, Delattre O.

PLoS One. 2009;4(1):e4107. doi: 10.1371/journal.pone.0004107. Epub 2009 Jan 1.

9.

Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG.

Cancer Res. 2001 Sep 15;61(18):6713-5.

10.

Oligodendrogliomas: new insights from the genetics and perspectives.

Alentorn A, Sanson M, Idbaih A.

Curr Opin Oncol. 2012 Nov;24(6):687-93. doi: 10.1097/CCO.0b013e328357f4ea. Review.

PMID:
22913971
11.

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.

Clin Cancer Res. 2002 Jan;8(1):196-201.

12.

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW.

Front Biosci. 2003 Jan 1;8:a1-9.

PMID:
12456321
13.

Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q.

Vajtai I, Arnold M, Vassella E.

Acta Neuropathol. 2005 Nov;110(5):520-2. Epub 2005 Oct 13. No abstract available.

PMID:
16222523
14.

Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.

Katsetos CD, Del Valle L, Geddes JF, Aldape K, Boyd JC, Legido A, Khalili K, Perentes E, Mörk SJ.

J Neuropathol Exp Neurol. 2002 Apr;61(4):307-20.

PMID:
11939586
15.

Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion.

Hewer E, Beck J, Vassella E, Vajtai I.

Neuropathology. 2014 Feb;34(1):32-8. doi: 10.1111/neup.12043. Epub 2013 May 27.

PMID:
23711170
16.

Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.

Sonabend AM, Lesniak MS.

Expert Rev Neurother. 2005 Nov;5(6 Suppl):S25-32. Review.

PMID:
16274268
18.

Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas.

Figarella-Branger D, Mokhtari K, Dehais C, Carpentier C, Colin C, Jouvet A, Uro-Coste E, Forest F, Maurage CA, Vignaud JM, Polivka M, Lechapt-Zalcman E, Eimer S, Viennet G, Quintin-Roué I, Aubriot-Lorton MH, Diebold MD, Loussouarn D, Lacroix C, Rigau V, Laquerrière A, Vandenbos F, Michalak S, Sevestre H, Peoch M, Labrousse F, Christov C, Kemeny JL, Chenard MP, Chiforeanu D, Ducray F, Idbaih A, Delattre JY; POLA Network.

Neuro Oncol. 2016 Jun;18(6):888-90. doi: 10.1093/neuonc/now085. No abstract available.

19.

Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas.

Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA.

Acta Neuropathol. 2005 Apr;109(4):387-92. Epub 2005 Mar 1.

PMID:
15739101
20.

Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.

Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.

Genes Chromosomes Cancer. 2005 Jan;42(1):68-77.

PMID:
15472895

Supplemental Content

Support Center